Skip to content

SOL SCIENTIFICS: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

SOL SCIENTIFICS

BE 0745.850.717
NACE 47.741, Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
financial year 2026 compared with 2025filed annual accounts (NBB)
Net result for the year
-€11,710
2025 · -€54,306+€42,596
Equity
-€37,541
2025 · -€25,831-€11,710
Cash
€28,421
2025 · €10,149+€18,271
Balance sheet total
€426,554
2025 · €359,751+€66,804

Largest movements

2025 to 2026
Assets
  • Intangible fixed assets +€65,156

    new in 2026: €65,156

  • Tangible fixed assets -€22,960

    down €22,960 (-6.6%), from €347,531 to €324,571

    of which Land and buildings: -€20,918

  • Cash +€18,271

    up €18,271 (+180%), from €10,149 to €28,421

    mainly Other debts (+€88,119) and Depreciation (+€25,509)

  • Receivables within one year +€6,460

    up €6,460 (+360%), from €1,797 to €8,257

    of which Other amounts receivable: +€4,939

Equity and liabilities
  • Other debts +€88,119

    up €88,119 (+69.1%), from €127,608 to €215,727

  • Debts after one year -€13,677

    down €13,677 (-5.8%), from €237,023 to €223,347

  • Profit (loss) carried forward -€11,710

    down €11,710 (-7.7%), from -€152,079 to -€163,789

  • Trade debts +€5,356

    up €5,356 (+118%), from €4,533 to €9,889

Income statement
  • Gross operating margin +€46,649

    up €46,649, from -€24,888 to €21,761

  • Depreciation +€4,031

    up €4,031 (+18.8%), from €21,478 to €25,509

From the 2025 result to the 2026 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2025 -€54,306
Gross operating margin +€46,649
Depreciation -€4,031
Other operating charges -€191
Financial income +€0
Financial charges +€169
Result 2026 -€11,710
raises the resultlowers the result

Derived cash bridge

cash 2025 to 2026

Derived from the 2025 and 2026 balance sheets and the 2026 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€99,419
Investment -€67,705
Financing -€13,443
Cash 2025 €10,149
Net result for the year -€11,710
Depreciation +€25,509
Receivables within one year -€6,460
Smaller working-capital items +€106
Trade debts +€5,356
Advances received -€1,500
Other debts +€88,119
Investment in fixed assets (net) -€67,705
Debts after one year -€13,677
Current portion of long-term debt +€233
Cash 2026 €28,421
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2025 2026 Change %
Total assets 20/58 €359,751 €426,554 +€66,804 +18.6%
Fixed assets 21/28 €347,531 €389,727 +€42,196 +12.1%
Intangible fixed assets 21 - €65,156 +€65,156
Tangible fixed assets 22/27 €347,531 €324,571 -€22,960 -6.6%
Land and buildings 22 €343,477 €322,559 -€20,918 -6.1%
Plant, machinery and equipment 23 €4,054 €2,012 -€2,042 -50.4%
Current assets 29/58 €12,220 €36,827 +€24,607 +201%
Stocks and contracts in progress 3 €0 - =
Stocks 30/36 €0 - =
Amounts receivable within one year 40/41 €1,797 €8,257 +€6,460 +360%
Trade receivables 40 €1,179 €2,700 +€1,521 +129%
Other amounts receivable 41 €617 €5,557 +€4,939 +800%
Cash at bank and in hand 54/58 €10,149 €28,421 +€18,271 +180%
Deferred charges and accrued income 490/1 €274 €150 -€124 -45.2%
Total equity and liabilities 10/49 €359,751 €426,554 +€66,804 +18.6%
Equity 10/15 -€25,831 -€37,541 -€11,710 -45.3%
Contributions 10/11 €5,000 €5,000 = 0.0%
Reserves 13 €121,248 €121,248 = 0.0%
Distributable reserves 133 €121,248 €121,248 = 0.0%
Profit (loss) carried forward 14 -€152,079 -€163,789 -€11,710 -7.7%
Amounts payable 17/49 €385,582 €464,095 +€78,514 +20.4%
Amounts payable after more than one year 17 €237,023 €223,347 -€13,677 -5.8%
Financial debts 170/4 €237,023 €223,347 -€13,677 -5.8%
Amounts payable within one year 42/48 €148,214 €240,423 +€92,209 +62.2%
Current portion of amounts payable after more than one year 42 €14,573 €14,806 +€233 +1.6%
Trade debts 44 €4,533 €9,889 +€5,356 +118%
Suppliers 440/4 €4,533 €9,889 +€5,356 +118%
Advances received on contracts in progress 46 €1,500 €0 -€1,500 -100%
Other amounts payable 47/48 €127,608 €215,727 +€88,119 +69.1%
Accrued charges and deferred income 492/3 €344 €326 -€18 -5.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €21,478 €25,509 +€4,031 +18.8%
Other operating charges 640/8 €3,774 €3,965 +€191 +5.1%
Gross operating margin 9900 -€24,888 €21,761 +€46,649
Operating profit (loss) 9901 -€50,140 -€7,713 +€42,427 +84.6%
Financial income 75/76B €0 €0 +€0
Recurring financial income 75 €0 €0 +€0
Financial charges 65/66B €4,166 €3,998 -€169 -4.0%
Recurring financial charges 65 €4,166 €3,998 -€169 -4.0%
Profit (loss) for the period before taxes 9903 -€54,306 -€11,710 +€42,596 +78.4%
Profit (loss) for the period 9904 -€54,306 -€11,710 +€42,596 +78.4%
Profit (loss) for the period to be appropriated 9905 -€54,306 -€11,710 +€42,596 +78.4%

Source: filed annual accounts (NBB), financial years ended 31 March 2025 and 31 March 2026. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.